Any substantial reduction in gun violence will require a comprehensive approach to the issue, write the authors of a report on the reality of firearm violence in the Houston area.
Ned Levine, Bindi Naik-Mathuria, Cary Cain, Lisa Pompeii, Abiodun OluyomiMay 30, 2023
In this report, fellow Tony Payan examines three recent U.S. criminal cases involving high-ranking Mexican officials. These cases point to a new “policy” by Washington to use its long-arm jurisdiction to arrest, prosecute and punish Mexican officials who have committed crimes that harm U.S. interests, he writes.
Despite the many potential challenges — including difficulties conserving water, using clean energy and dealing with the López Obrador administration — Tesla will most likely move forward with the construction of a “gigafactory" in Mexico. In this issue brief, fellow David Gantz explains why the benefits outweigh the risks.
The market for stem cell therapies is growing, but most of these treatments are still experimental — and patients who undergo them risk experiencing serious side effects. This quick take offers three recommendations to improve patient safety and education around stem cell interventions in Texas.
Mexican President Andrés Manuel López Obrador's deference to drug cartels in Mexico reveals that he is not interested in meaningful cooperation on bilateral drug law enforcement, and his administration should be regarded as hostile to U.S. interests, writes nonresident fellow Gary Hale.
LOGINK offers Beijing a means to monitor and shape the international logistics market, increase foreign strategic dependency on China, and exploit the vulnerabilities of LOGINK users for economic and geostrategic purposes.
Nonresident scholar Richard Kilroy explores how Mexican President Andrés Manuel López Obrador’s decision to move the Guardia Nacional — an institution created to protect public safety — under the control of Mexico’s military could have dire consequences for civil-military relations and U.S.-Mexico security relations.
The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.
Driven by the USMCA trade agreement and seeking to reduce supply chain disruptions, Chinese companies are setting up shop in Mexico, closer to major U.S. markets. In this issue brief, fellow David Gantz explains the pressures behind this investment and the likely impacts on the North American economy.